| Size | Price | Stock |
|---|---|---|
| 100 mg | Get quote | |
| 250 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-106204 |
| M.Wt: | 995.21 |
| Formula: | C50H78N10O11 |
| Purity: | >98 % |
| Solubility: | H2O |
Nelipepimut-S (E75) is a peptide vaccine targeting HER2. When used in combination with granulocyte-macrophage colony-stimulating factor, Nelipepimut-S stimulates immune activity and induces anti-HER2 immune responses. Nelipepimut-S can be used in research related to breast cancer, triple-negative breast cancer and ductal carcinoma in situ[1][2].
In Vitro:Nelipepimut-S acts as the HLA-A2 immunodominant epitope of HER2, potently stimulating cell lysis by ovarian cancer reactive CTL lines and demonstrating high HLA-A2 stabilizing ability[2].
Nelipepimut-S is presented on HLA-A2 in ovarian cancer cell lines and is recognized by ovarian cancer-associated CD8+ T-cell clones[2].
In Vivo:Nelipepimut-S elicits a HER2-specific CTL response that mediates in vivo lysis of HER2-expressing tumor cells in transgenic mice[2].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.